Výpis publikací

KNIGHT, Andrea. Innate immunity in B-cell malignancies. In B cell Symposium. 2025.

HUDEČEK, Robert; Martin PISKÁČEK; Marie TOMANDLOVÁ a Andrea KNIGHT. Plasmacytoid dendritic cells in endometriosis patients. In SEUD congress, Prague 24-26th April 2025. 2025.

KNIGHT, Andrea; Martin PISKÁČEK; Marie TOMANDLOVÁ; Tereza SLAMEČKOVÁ; Jiřina PROCHÁZKOVÁ; Daniela ŽÁČKOVÁ a Jiří MAYER. Expression of the immune checkpoint inhibitors on gamma-delta T cells in chronic myeloid leukemia patients during TKI therapy. In ESH-iCMLf 26th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy. 2024.

KNIGHT, Andrea; Martin PISKÁČEK; Marie TOMANDLOVÁ; Hana ŠKABRAHOVÁ; Martina ORSULOVA a Michael DOUBEK. Gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia. In UK CLL FORUM 2024, March 8th, 2024. 2024.

JURÁŇ, Vilém; Václav VYBÍHAL; Marek SOVA; Martin SMRČKA; Tomáš KAZDA; Martin PISKÁČEK a Andrea KNIGHT. Harnessing the EphA2 blockade in glioblastoma. In 4th congress on the Eph-ephrin system, Parma, Italy, May 16-17, 2024. 2024.

KNIGHT, Andrea; Martin PISKÁČEK; Marie TOMANDLOVÁ; Hana ŠKABRAHOVÁ; Martina ORSULOVA a Michael DOUBEK. Innate effector gamma-delta T cells in newly diagnosed patients with chronic lymphocytic leukaemia. In Cambridge Immunology Forum: New concepts in innate immunity, September 23rd, 2024. 2024.

KNIGHT, Andrea; Josef HOUSER; Tomáš OTAŠEVIČ; Vilém JURÁŇ; Václav VYBÍHAL; Martin SMRČKA a Martin PISKÁČEK. Myc 9aaTAD activation domain binds to mediator of transcription with superior high affinity. Molecular Medicine. New York: SPRINGER, 2024, roč. 30, č. 1, s. 1-9. ISSN 1076-1551. Dostupné z: https://dx.doi.org/10.1186/s10020-024-00896-7.

VYBÍHAL, Václav; Vilém JURÁŇ; Tomáš KAZDA; Marek SOVA; Pavel FADRUS; Martin SMRČKA; Martin PISKÁČEK a Andrea KNIGHT. Blockade of PD-L1 and B7-H3 checkpoint inhibitor ligands in glioblastoma. In International Cancer Immunotherapy Conference CICON23. 2023.

KNIGHT, Andrea; Martin PISKÁČEK; Michal JURAJDA; Jiřina PROCHÁZKOVÁ; Zdeněk RÁČIL; Daniela ŽÁČKOVÁ a Jiří MAYER. Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia. Cancer immunology, immunotherapy. NEW YORK: SPRINGER, 2023, roč. 72, č. 5, s. 1209-1224. ISSN 0340-7004. Dostupné z: https://dx.doi.org/10.1007/s00262-022-03312-3.

KNIGHT, Andrea; Lucie KRISTOVÁ; Tereza SLAMEČKOVÁ; Marie TOMANDLOVÁ; Martin PISKÁČEK a Robert HUDEČEK. Gamma-delta T cells in patients with endometriosis. In 15th World Congress on Endometriosis 3rd-6th May Edinburgh. 2023.

KNIGHT, Andrea; Josef HOUSER; Vilém JURÁŇ; Václav VYBÍHAL; Pavel FADRUS; Martin SMRČKA a Martin PISKÁČEK. Targeting undruggable oncoproteins c-Myc and N-Myc by the 9aaTADs. In Advanced Therapies 2023, 14-15 March 2023, ExCeL, London. 2023.

HOUSER, Josef; Kristína JENDRUCHOVÁ; Andrea KNIGHT a Martin PISKÁČEK. The NFkB activation domain is 14-amino-acid-long variant of the 9aaTAD. The Biochemical journal. LONDON: PORTLAND PRESS LTD, 2023, roč. 480, č. 5, s. 297-306. ISSN 0264-6021. Dostupné z: https://dx.doi.org/10.1042/BCJ20220605.

TOLOCHOVA, Petra; Martin PISKÁČEK; Renata HÉŽOVÁ; Elleni MICHU; Ondřej SLABÝ a Andrea KNIGHT. CMV-reactive Vdelta1 gd T cells are equally cytotoxic to CMV-specific ab T cells in HLA-A*02 healthy donors. In 8th International Congenital CMV Conference & 18th International CMV Workshop, 28th March-1st April 2022 Cambridge. 2022.

KNIGHT, Andrea a Martin PISKÁČEK. Cryptic inhibitory regions nearby activation domains. Biochimie. ISSY-LES-MOULINEAUX: Elsevier, 2022, roč. 200, September 2022, s. 19-26. ISSN 0300-9084. Dostupné z: https://dx.doi.org/10.1016/j.biochi.2022.05.004.

TOMANDLOVÁ, Marie; Martin PISKÁČEK; Vilém JURÁŇ; Marek SOVA; Martin SMRČKA; Václav VYBÍHAL; Pavel FADRUS; Tomáš KAZDA a Andrea KNIGHT. Plasma levels of immune checkpoint inhibitor ligands PD-L1, B7-H3 and galectin-9 in glioblastoma patients. In Brain Tumour Conference 2022, 5-7 September 2022, London. 2022.

JURÁŇ, Vilém; Martin PISKÁČEK; Marie TOMANDLOVÁ; Marek SOVA; Martin SMRČKA; Tomáš KAZDA; Václav VYBÍHAL; Pavel FADRUS a Andrea KNIGHT. Tumor infiltration of gamma-delta T cells in glioblastoma. In 27th Annual Meeting and Education Day of the Society for Neuro-Oncology November 16 - 20, 2022, Tampa Convention Center, Tampa Bay, FL. 2022.

HUDEČEK, Robert; Barbora KOHLOVÁ; Ingrid SISKOVA; Martin PISKÁČEK a Andrea KNIGHT. Blocking of EphA2 on Endometrial Tumor Cells Reduces Susceptibility to Vδ1 Gamma-Delta T-Cell-Mediated Killing. Frontiers in Immunology. Lausanne: Frontiers, 2021, roč. 12, October 2021, s. 1-12. ISSN 1664-3224. Dostupné z: https://dx.doi.org/10.3389/fimmu.2021.752646.

KOHLOVÁ, Barbora; Martin PISKÁČEK; Marie TOMANDLOVÁ; Veronika MOTÚZOVÁ; Vít ZMÁTLO; Vilém JURÁŇ; Marek SOVA; Václav VYBÍHAL; Pavel FADRUS; Tomáš KAZDA a Andrea KNIGHT. Gamma-delta T cells in Glioblastoma patients. In The 9th International γδ T Cell Conference. 2021.

KOHLOVÁ, Barbora; Martin PISKÁČEK; Marie TOMANDLOVÁ; Veronika MOTÚZOVÁ; Vít ZMÁTLO; Vilém JURÁŇ; Marek SOVA; Václav VYBÍHAL; Pavel FADRUS; Tomáš KAZDA a Andrea KNIGHT. Gamma-delta T cells in Glioblastoma patients. In The 9th International γδ T Cell Conference. 2021.

JURÁŇ, Vilém; Barbora KOHLOVÁ; Martin PISKÁČEK; Vít ZMÁTLO; Leonard JAKUBÁČ; Veronika MOTÚZOVÁ; Marie TOMANDLOVÁ; Marek SOVA; Tomáš KAZDA; Václav VYBÍHAL; Pavel FADRUS a Andrea KNIGHT. Infiltration of Gamma-delta T cells into Glioblastoma Tumor. In WFNOS 2022 - the World Federation of Neuro-Oncology Societies (WFNOS), Seoul, South Korea. 2021.

KNIGHT, Andrea; Lucie ŘÍHOVÁ; Romana KRÁLOVÁ; Miroslav PENKA; Zdeněk ADAM; Luděk POUR; Martin PISKÁČEK a Roman HAJEK. Plasmacytoid Dendritic Cells in Patients with MGUS and Multiple Myeloma. Journal of Clinical Medicine. Basel: MDPI, 2021, roč. 10, č. 16, s. 1-11. ISSN 2077-0383. Dostupné z: https://dx.doi.org/10.3390/jcm10163717.

PISKÁČEK, Martin; Tomáš OTAŠEVIČ; Martin REPKO a Andrea KNIGHT. The 9aaTAD Activation Domains in the Yamanaka Transcription Factors Oct4, Sox2, Myc, and Klf4. Stem Cell Reviews and Reports. NEW YORK: SPRINGER, 2021, roč. 17, č. 5, s. 1934-1936. ISSN 2629-3269. Dostupné z: https://dx.doi.org/10.1007/s12015-021-10225-8.

KNIGHT, Andrea; Barbora KOHLOVÁ; Martin PISKÁČEK; Vít ZMÁTLO; Marie TOMANDLOVÁ; Marek SOVA; Vilém JURÁŇ; Tomáš KAZDA; Václav VYBÍHAL a Pavel FADRUS. Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme. In XLV. Brněnské onkologické dny. 2021. ISSN 0862-495X.

KNIGHT, Andrea; Barbora KOHLOVÁ; Martin PISKÁČEK; Vít ZMÁTLO; Marie TOMANDLOVÁ; Marek SOVA; Vilém JURÁŇ; Tomáš KAZDA; Václav VYBÍHAL a Pavel FADRUS. Úloha cytotoxických gamma-delta T buněk na terapeutické rezistenci a recidivě Glioblastoma Multiforme. In XLV. Brněnské onkologické dny. 2021.

HOFROVÁ, Alena; Petr LOUŠA; Monika KUBÍČKOVÁ; Jozef HRITZ; Tomáš OTAŠEVIČ; Martin REPKO; Andrea KNIGHT a Martin PISKÁČEK. Universal two-point interaction of mediator KIX with 9aaTAD activation domains. Journal of cellular biochemistry. Hoboken (USA): WILEY-BLACKWELL, 2021, roč. 122, č. 10, s. 1544-1555. ISSN 0730-2312. Dostupné z: https://dx.doi.org/10.1002/jcb.30075.

KNIGHT, Andrea. Detekce myeloidních supresorových buněk v nádorovém mikroprostředí. In Odborný seminář I.T.A.-Intertact s.r.o. 2020.

KNIGHT, Andrea; Robert HUDEČEK; Martin PISKÁČEK; Barbora KOHLOVÁ a Ingrid SISKOVÁ. Innate gamma-delta T cells in endometriosis. In 30. sympozium Asistované reprodukce a 19. česko-slovenské konference Reprodukční gynekologie. 2020.

KNIGHT, Andrea; Robert HUDEČEK; Martin PISKÁČEK; Barbora KOHLOVÁ a Ingrid SISKOVÁ. Innate gamma-delta T cells in endometriosis. In 30. sympozium Asistované reprodukce a 19. česko-slovenské konference Reprodukční gynekologie. 2020.

KAZDA, Tomáš; Radek LAKOMÝ; Alexandr POPRACH; Michal HENDRYCH; Andrea KNIGHT a Pavel ŠLAMPA. Multidisciplinární přístup v léčbě gliomů - astrocytomy a oligodendrogliomy. Postgraduální medicína. Praha: Mladá fronta, 2020, roč. 22, č. 2, s. 137-142. ISSN 1212-4184.

LAKOMÝ, Radek; Tomáš KAZDA; Iveta SELINGEROVÁ; Alexandr POPRACH; Petr POSPÍŠIL; Renata BELANOVÁ; Pavel FADRUS; Martin SMRČKA; Václav VYBÍHAL; Radim JANČÁLEK; Igor KISS; Katarína MÚČKOVÁ; Michal HENDRYCH; Andrea KNIGHT; Jiří ŠÁNA; Pavel ŠLAMPA a Ondřej SLABÝ. Pre-Radiotherapy Progression after Surgery of Newly Diagnosed Glioblastoma: Corroboration of New Prognostic Variable. Diagnostics. Basel: MDPI, 2020, roč. 10, č. 9, s. 1-13. ISSN 2075-4418. Dostupné z: https://dx.doi.org/10.3390/diagnostics10090676.

PISKÁČEK, Martin; Marek HAVELKA; Kristína JENDRUCHOVÁ; Andrea KNIGHT a Liam KEEGAN. The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with valines and intron reservoirs. Cellular and molecular life sciences. BASEL: BIRKHAUSER VERLAG AG, 2020, roč. 77, č. 9, s. 1793-1810. ISSN 1420-682X. Dostupné z: https://dx.doi.org/10.1007/s00018-019-03251-w.

PISKÁČEK, Martin; Marek HAVELKA; Kristína JENDRUCHOVÁ a Andrea KNIGHT. Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA activation pathways. Journal of steroid biochemistry and molecular biology. Oxford: Pergamon-Elsevier Science, 2019, roč. 187, MAR 2019, s. 118-123. ISSN 0960-0760. Dostupné z: https://dx.doi.org/10.1016/j.jsbmb.2018.11.008.

PISKÁČEK, Martin; Romana KRÁLOVÁ; Maria KRCHNIAKOVA; Michael DOUBEK a Andrea KNIGHT. Tumour-reactive gamma-delta T cells targeting the EphA2 receptor in B- cell CLL. In The 8th International γδ T-Cell Conference Bordeaux, France, 7 - 10 June May 2018. 2018.

KNIGHT, Andrea. Vybrané markery nádorových buněk jako terapeutické cíle B-buněčných malignit. In Seminář I.T.A. - Interact s.r.o., Praha, 2018. 2018.

PISKÁČEK, Martin; Marek HAVELKA; Martina ŘEZÁČOVÁ a Andrea KNIGHT. The 9aaTAD Is Exclusive Activation Domain in Gal4. Plos one. San Francisco: Public Library of Science, 2017, roč. 12, č. 1, s. 1-13. ISSN 1932-6203. Dostupné z: https://dx.doi.org/10.1371/journal.pone.0169261.

KNIGHT, Andrea. Tumour reactive Gamma Delta T Cells in Haematology. In CCIT - Center for Cancer Immune Therapy, Copenhagen, 27th March 2017. 2017.

KNIGHT, Andrea. Turning up the heat on human gamma-delta T cells in malignant disease. In Vyžádaná přednáška na University Bordeaux. 2017.

KNIGHT, Andrea; Martin PISKÁČEK; Romana KRÁLOVÁ; Mária KRCHNIAKOVÁ; Petra GALLOVÁ; Martin KUBEŠ; Lucie RIHOVA; Pavla VSIANSKA; Rita PACASOVA; Miroslav PENKA; Zdenek ADAM; Ludek POUR; Roman HAJEK a Anna VAŠKŮ. Analysis of anti-tumour and anti-viral reactivities of human gamma-delta T cells. In Gamma Delta Conference 2016. 2016.

KRÁLOVÁ, Romana; Lucie RIHOVA; Pavla VSIANSKA; Mária KRCHNIAKOVÁ; Martin PISKÁČEK; Rita PACASOVA; Miroslav PENKA; Zdenek ADAM; Ludek POUR; Roman HAJEK a Andrea KNIGHT. Analysis of gamma-delta T cells and plasmacytoid dendritic cells in MGUS and Multiple Myeloma patients. In Gamma Delta Conference 2016. 2016.

KRCHNIAKOVÁ, Mária; Lucie RIHOVA; Romana KRÁLOVÁ; Rita PACASOVA; Miroslav PENKA; Zdenek ADAM; Ludek POUR; Roman HAJEK; Martin PISKÁČEK a Andrea KNIGHT. Analysis of the EphA2 Receptor Expression on Malignant Plasma Cells and Plasmacytoid Dendritic Cells in MGUS and Multiple Myeloma Patients. In Gamma Delta Conference 2016. 2016.

KRCHNIAKOVÁ, Mária; Romana KRÁLOVÁ; Martin PISKÁČEK a Andrea KNIGHT. Analýza expresie receptorov EphA1 a EphA2 u nádorových bunkových línií. In XXX. Olomoucké hematologické dny. 2016.

KRÁLOVÁ, Romana; Lucie ŘÍHOVÁ; Pavla VŠIANSKÁ; Mária KRCHNIAKOVÁ; Martin PISKÁČEK; Rita PACASOVÁ; Miroslav PENKA; Zdeněk ADAM; Luděk POUR; Roman HÁJEK a Andrea KNIGHT. Buněčná analýza plasmacytoidních dendritických buněk u mnohočetného myelomu. In XXX. Olomoucké hematologické dny. 2016.

KNIGHT, Andrea; Pavel NĚMEC; Soňa BRETZOVÁ; Lucie VÁLKOVÁ; Markéta KOLMANOVÁ; Renáta VYTOPILOVÁ; Marek HAVELKA; Pavla VSIANSKA; Lucie RIHOVA; Marta KREJČÍ a Martin PISKÁČEK. Do human B-lymphocytes avoid aging until 60 years? Oncotarget. New York: Impact Journals, 2016, roč. 7, č. 28, s. 42873-42880. ISSN 1949-2553. Dostupné z: https://dx.doi.org/10.18632/oncotarget.10146.

PISKÁČEK, Martin; Marek HAVELKA; Martina ŘEZÁČOVÁ a Andrea KNIGHT. The 9aaTAD Transactivation Domains: From Gal4 to p53. Plos one. San Francisco: Public Library of Science, 2016, roč. 11, č. 9, s. 1-16. ISSN 1932-6203. Dostupné z: https://dx.doi.org/10.1371/journal.pone.0162842.

PISKACEK, Martin; Anna VAŠKŮ; Roman HÁJEK a Andrea KNIGHT. Shared structural features of the 9aaTAD family in complex with CBP. Molecular BioSystems. Cambridge: Royal Society of Chemistry, 2015, roč. 11, č. 3, s. 844-851. ISSN 1742-206X. Dostupné z: https://dx.doi.org/10.1039/C4MB00672K.

PRIETO-HINOJOSA, A.; Andrea KNIGHT; C. COMPTON; C. GLEESON a P.J. TRAVERS. Reduced thymic output in elite athletes. Brain, Behavior, and Immunity. Orlando, FL, USA: Academic Press, Orlando, FL, 2014. ISSN 0889-1591. Dostupné z: https://dx.doi.org/10.1016/j.bbi.2014.01.004.

KNIGHT, Andrea; Martin PISKACEK; Pavla VŠIANSKÁ; Rita PACASOVÁ a Anna VAŠKŮ. ROLE OF CYTOMEGALOVIRUS SEROPOSITIVITY ON AGEING OF THE INNATE IMMUNE SYSTEM OF GAMMA-DELTA T CELLS IN HEALTHY DONORS. In The Ageing Summit 2014, Londýn. 2014.

KNIGHT, Andrea. Vdelta1 T cells represent a dominant gamma-delta T cell subset in patients with multiple myeloma. In Tumor Immunology Immunotherapy Torino Conference (TIITC). 2014.

KNIGHT, Andrea; Hilal ARNOUK; William BRITT; G. Yancey GILLESPIE; Gretchen A. CLOOUD; Lualhati HARKINS; Yun SU; Mark W. LOWDELL a Lawrence S. LAMB. CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vdelta1+ gamma-delta T Cells. PLoS One. San Francisco, CA, USA: Public Library of Science, 2013, roč. 8, č. 8, s. e68729, 10 s. ISSN 1932-6203. Dostupné z: https://dx.doi.org/10.1371/journal.pone.0068729.

KNIGHT, Andrea; Lucie ŘÍHOVÁ; Tamara VARMUŽOVÁ; Pavla VŠIANSKÁ; Martin PISKACEK; Fedor KRYUKOV; S. MACKINNON a Roman HÁJEK. Human Vdelta1 T cells represent a dominant gamma-delta T cell subset in patients with multiple myeloma. In 18th Congress of the European Hematology Association, Stockholm, Sveden. 2013. ISSN 0390-6078.

KNIGHT, Andrea; Pavla VŠIANSKÁ; Martin PISKACEK; Pavel NĚMEC; Luděk POUR; Zdeněk ADAM a Roman HÁJEK. Interactions of plasmacytoid dendritic cells with myeloma plasma cells and gamma/delta T cells in MGUS and multiple myeloma patients. In ESH International Conference on Multiple Myeloma, Dublin, Ireland. 2013.

KNIGHT, Andrea. Investigations of gamma-delta T cells in patients with monoclonal gammopathy. In Seminar to the students of the International PhD Program in Immunopharmacology at the University of Palermo. 2013.

KNIGHT, Andrea; Stephen MACKINNON a Mark W. LOWDELL. Vdelta1 gamma-delta T cell-mediated killing of myeloma cells: a new candidate for immunotherapy. In XIV. International Myeloma Workshop, Kyoto, Japan. 2013. ISSN 2152-2650.

KNIGHT, Andrea; Stephen MACKINNON a Mark W. LOWDELL. Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells. Cytotherapy. United Kingdom: Oxford, England : ISIS Medical Media, 2012, roč. 14, č. 9, s. 1110-8, 9 s. ISSN 1465-3249. Dostupné z: https://dx.doi.org/10.3109/14653249.2012.700766.

KNIGHT, Andrea; Stephen MACKINNON a Mark W. LOWDELL. CMV-Reactive gamma/delta T Cells Are Equivalent to Their alpha/beta Counterparts In the Lysis of CMV-Infected Targets – Potential for Post Transplant Adoptive Immunotherapy. In 52nd ASH® Annual Meeting and Exposition, Orlando, USA. 2010. ISSN 0006-4971.

KNIGHT, Andrea; AJ. MADRIGAL; S. GRACE; J. SIVAKUMARAN; P. KOTTARIDIS; S . MACKINNON; PJ. TRAVERS a MW. LOWDELL. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation. Blood. Washington, DC, United States: American Society of Hematology, 2010, roč. 116, č. 12, s. 2164-72, 9 s. ISSN 0006-4971. Dostupné z: https://dx.doi.org/10.1182/blood-2010-01-255166.